Breaking News Instant updates and real-time market news.

CAPR

Capricor Therapeutics

$1.43

-0.07 (-4.67%)

07:08
04/19/18
04/19
07:08
04/19/18
07:08

Capricor announces new pre-clinical data on CAP-1002

Capricor Therapeutics announced that researchers found that repeat dosing of the company's proprietary cellular therapy yields an increase in exercise performance in a disease model of Duchenne muscular dystrophy, the mdx mouse. The company has previously presented data showing that single doses lead to significant improvement in treadmill run times. In an abstract presentation at the 11th Annual Neuromuscular Translational Research Conference in Cambridge, England, researchers reported that while the therapy, CAP-1002, is recognized by the immune system, its low immunogenic profile and immunomodulatory capabilities allowed it to be administered multiple times without significant safety issues. They also reported that repeat dosing was shown to sustain the effect of the therapeutic. A previous clinical trial, the HOPE-Duchenne trial, found a single intracoronary dose of CAP-1002 was generally safe, well tolerated and demonstrated significant and sustained signals of improvement in cardiac and skeletal muscle function in boys and young men in advanced stages of Duchenne muscular dystrophy. The HOPE-2 clinical trial will test the safety and efficacy of repeat doses of CAP-1002 in boys and young men with Duchenne muscular dystrophy, a devastating and fatal genetic disorder with limited treatment options and no cure. Up to 84 boys and young men with Duchenne muscular dystrophy will be enrolled in the Phase 2, randomized, double-blind, placebo-controlled trial. HOPE-2 will test repeat doses of CAP-1002 in participants with advanced stages of Duchenne muscular dystrophy. Capricor has been granted the RMAT and orphan disease designations by the U.S. Food and Drug Administration. These designations will enable the company to work closely with the FDA in finalizing the regulatory approval pathway for CAP-1002 and to receive expedited FDA reviews.

CAPR Capricor Therapeutics
$1.43

-0.07 (-4.67%)

07/18/17
RODM
07/18/17
NO CHANGE
Target $2.15
RODM
Buy
FDA decision encouraging for Capricor Duchenne drug, says Rodman & Renshaw
Rodman & Renshaw analyst Joseph Pantginis notes that Capricor Therapeutics' CAP-1002 took an important regulatory step forward with the FDA granting Rare Pediatric Disease Designation for Duchenne muscular dystrophy. Should the positive CAP-1002 data continue to be positive and the therapy approved, Capricor could also be eligible for a Priority Review Voucher, or PRV, the analyst points out, adding that a key potential outcome to a PRV is not only an accelerated path to market, but the ability to sell the PRV for significant non-dilutive funding. Pantginis reiterates a Buy rating and $2.15 price target on the shares. In late morning trading, Capricor Therapeutics' stock has more than doubled to $1.44.
09/15/17
HCWC
09/15/17
NO CHANGE
Target $6.5
HCWC
Buy
Capricor Therapeutics price target raised to $6.50 from $2.15 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target Capricor Therapeutics to $6.50 after increasing his projected chance of success for CAP-1002 in Duchenne muscular dystrophy to 15% from 5%. The analyst sees "significant" FDA visibility for the company's DMD program and believe catalysts next quarter could "reinvigorate interest in the shares." He keeps a Buy rating on Capricor.
01/26/18
HCWC
01/26/18
NO CHANGE
Target $8.6
HCWC
Buy
Capricor Therapeutics price target raised to $8.60 from $6.50 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for Capricor Therapeutics to $8.60 following a meeting with management. The analyst increased his projected chance of success for CAP-1002 in Duchenne muscular dystrophy from 15% to 20% and reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

SNPS

Synopsys

$90.29

1.05 (1.18%)

21:14
05/23/18
05/23
21:14
05/23/18
21:14
Recommendations
Synopsys analyst commentary at JPMorgan »

Synopsys benefited from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

AMZN

Amazon.com

$1,601.77

19.67 (1.24%)

21:04
05/23/18
05/23
21:04
05/23/18
21:04
Periodicals
Amazon Web Services to invest in Chile as part of LatAm expansion, Reuters says »

Amazon Web Services is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

SRRK

Scholar Rock

$0.00

(0.00%)

21:01
05/23/18
05/23
21:01
05/23/18
21:01
Syndicate
Scholar Rock 5.36M share IPO priced at $14.00 »

The deal priced in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

KNSA

Kiniksa

$0.00

(0.00%)

21:00
05/23/18
05/23
21:00
05/23/18
21:00
Syndicate
Kiniksa 8.5M share IPO priced at $18.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

GSKY

GreenSky

$0.00

(0.00%)

20:58
05/23/18
05/23
20:58
05/23/18
20:58
Syndicate
GreenSky 38M share IPO priced at $23.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

SAIL

SailPoint

$23.30

1.29 (5.86%)

20:56
05/23/18
05/23
20:56
05/23/18
20:56
Syndicate
SailPoint 17.808M share Secondary priced at $22.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

CLPS

CLPS

$0.00

(0.00%)

20:55
05/23/18
05/23
20:55
05/23/18
20:55
Syndicate
CLPS 2M share IPO priced at $5.25 »

The deal priced between…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

MDT

Medtronic

$85.29

0.305 (0.36%)

, MCK

McKesson

$146.84

0.39 (0.27%)

20:25
05/23/18
05/23
20:25
05/23/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MDT

Medtronic

$85.29

0.305 (0.36%)

MCK

McKesson

$146.84

0.39 (0.27%)

BBY

Best Buy

$75.73

0.255 (0.34%)

HRL

Hormel Foods

$35.82

-0.01 (-0.03%)

TTC

Toro Company

$60.32

-0.08 (-0.13%)

SAFM

Sanderson Farms

$107.13

1.19 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

  • 24

    May

  • 24

    May

  • 24

    May

  • 29

    May

  • 30

    May

  • 02

    Jun

  • 05

    Jun

  • 12

    Jun

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 26

    Jun

BPOP

Popular

$46.94

-0.31 (-0.66%)

20:07
05/23/18
05/23
20:07
05/23/18
20:07
Hot Stocks
Popular announces early termination of FDIC shared-loss agreements »

Popular, Inc announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSM

Williams-Sonoma

$49.21

1.91 (4.04%)

20:04
05/23/18
05/23
20:04
05/23/18
20:04
Recommendations
Williams-Sonoma analyst commentary at Loop Capital »

Williams-Sonoma earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

EWY

iShares MSCI South Korea Index Fund

$74.45

0.73 (0.99%)

, SPY

SPDR S&P 500 ETF Trust

$273.37

0.8 (0.29%)

19:59
05/23/18
05/23
19:59
05/23/18
19:59
Periodicals
Breaking Periodicals news story on iShares MSCI South Korea Index Fund, SPDR S&P 500 ETF Trust, S&P 500 »

N Korea foreign ministry…

EWY

iShares MSCI South Korea Index Fund

$74.45

0.73 (0.99%)

SPY

SPDR S&P 500 ETF Trust

$273.37

0.8 (0.29%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$128.70

0.465 (0.36%)

19:39
05/23/18
05/23
19:39
05/23/18
19:39
Hot Stocks
Canadian court affirms dismissal of suit against Chevron subsidiary »

The Ontario Court of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EA

Electronic Arts

$133.49

1.31 (0.99%)

19:19
05/23/18
05/23
19:19
05/23/18
19:19
Hot Stocks
Electronic Arts CTO sells 10,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCL

Carnival

$64.67

-0.39 (-0.60%)

19:14
05/23/18
05/23
19:14
05/23/18
19:14
Periodicals
Carnival CEO expects China to become the largest cruise market, CNBC says »

In an interview with CNBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

PBR

Petrobras

$15.10

-0.6 (-3.82%)

19:11
05/23/18
05/23
19:11
05/23/18
19:11
Periodicals
Petrobras slashes diesel price 10% to resolve trucker protest, Reuters says »

Petrobras has opted to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$88.94

-0.24 (-0.27%)

19:05
05/23/18
05/23
19:05
05/23/18
19:05
Hot Stocks
Sarepta granted orphan status for DMD treatment golodirsen »

The FDA granted Sarepta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

BZLFF

Bunzl

$0.00

(0.00%)

19:03
05/23/18
05/23
19:03
05/23/18
19:03
Downgrade
Bunzl rating change at Goldman Sachs »

Bunzl downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WUBA

58.com

$84.56

1.39 (1.67%)

19:02
05/23/18
05/23
19:02
05/23/18
19:02
Earnings
Breaking Earnings news story on 58.com »

58.com sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 10

    Sep

WUBA

58.com

$84.56

1.39 (1.67%)

19:01
05/23/18
05/23
19:01
05/23/18
19:01
Earnings
58.com reports Q1 adjusted earnings per ADS 33c, consensus 21c »

Reports Q1 revenue $393M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 10

    Sep

WSM

Williams-Sonoma

$49.21

1.91 (4.04%)

, LASR

nLight

$30.00

-1.79 (-5.63%)

18:58
05/23/18
05/23
18:58
05/23/18
18:58
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

WSM

Williams-Sonoma

$49.21

1.91 (4.04%)

LASR

nLight

$30.00

-1.79 (-5.63%)

SNPS

Synopsys

$90.29

1.05 (1.18%)

LB

L Brands

$34.05

0.06 (0.18%)

NTAP

NetApp

$66.61

-0.41 (-0.61%)

DGLY

Digital Ally

$2.55

-0.075 (-2.86%)

FCAU

Fiat Chrysler

$22.47

-0.155 (-0.69%)

TM

Toyota

$134.85

-0.89 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 24

    May

  • 11

    Jun

  • 12

    Jun

  • 10

    Jul

CPRT

Copart

$52.93

-0.06 (-0.11%)

18:54
05/23/18
05/23
18:54
05/23/18
18:54
Earnings
Copart reports Q3 adjusted EPS 52c, consensus 50c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

AAPL

Apple

$188.36

1.08 (0.58%)

, VLKAY

Volkswagen

$0.00

(0.00%)

18:45
05/23/18
05/23
18:45
05/23/18
18:45
Periodicals
Apple signs pact with VW over self-driving cars, NY Times says »

Apple (AAPL) has signed…

AAPL

Apple

$188.36

1.08 (0.58%)

VLKAY

Volkswagen

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$15.10

-0.6 (-3.82%)

18:24
05/23/18
05/23
18:24
05/23/18
18:24
Periodicals
Breaking Periodicals news story on Petrobras »

Petrobras under scrutiny…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$344.70

13.08 (3.94%)

, CMCSA

Comcast

$31.87

-0.64 (-1.97%)

18:03
05/23/18
05/23
18:03
05/23/18
18:03
Periodicals
Netflix market value now higher than Comcast, Recode says »

Netflix's (NFLX)…

NFLX

Netflix

$344.70

13.08 (3.94%)

CMCSA

Comcast

$31.87

-0.64 (-1.97%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$113.87

-0.05 (-0.04%)

18:01
05/23/18
05/23
18:01
05/23/18
18:01
Hot Stocks
Celanese to increase selling prices on acetyl intermediate products »

To raise prices on Vinyl…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.